These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2545451)

  • 1. A trial of RIT-4237 rotavirus vaccine in 1-month-old infants.
    Mutz ID; Krainer F; Deutsch J; Kunz C; Teuwen DE
    Eur J Pediatr; 1989 Jun; 148(7):634-5. PubMed ID: 2545451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine.
    Vesikari T; Isolauri E; D'Hondt E; Delem A; André FE; Zissis G
    Lancet; 1984 May; 1(8384):977-81. PubMed ID: 6143964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.
    Vesikari T; Rautanen T; Varis T; Beards GM; Kapikian AZ
    Am J Dis Child; 1990 Mar; 144(3):285-9. PubMed ID: 2154925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal rotavirus vaccination with RIT 4237 bovine rotavirus vaccine: a preliminary report.
    Vesikari T; Ruuska T; Delem A; André FE
    Pediatr Infect Dis J; 1987 Feb; 6(2):164-9. PubMed ID: 3031574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of two doses of RIT 4237 bovine rotavirus vaccine for prevention of rotavirus diarrhoea.
    Vesikari T; Ruuska T; Delem A; André FE; Beards GM; Flewett TH
    Acta Paediatr Scand; 1991 Feb; 80(2):173-80. PubMed ID: 1852084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants.
    Phua KB; Quak SH; Lee BW; Emmanuel SC; Goh P; Han HH; De Vos B; Bock HL
    J Infect Dis; 2005 Sep; 192 Suppl 1():S6-S16. PubMed ID: 16088807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic.
    Vesikari T; Isolauri E; Delem A; d'Hondt E; André FE; Beards GM; Flewett TH
    J Pediatr; 1985 Aug; 107(2):189-94. PubMed ID: 3894608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase IIIb study.
    Omenaca F; Sarlangue J; Szenborn L; Nogueira M; Suryakiran PV; Smolenov IV; Han HH;
    Pediatr Infect Dis J; 2012 May; 31(5):487-93. PubMed ID: 22228231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of bovine rotavirus vaccine RIT 4237 in 3-month-old infants.
    Maldonado Y; Hestvik L; Wilson M; Townsend T; O'Hare J; Wee S; Yolken R
    J Pediatr; 1986 Dec; 109(6):931-5. PubMed ID: 3537248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial.
    Armah GE; Sow SO; Breiman RF; Dallas MJ; Tapia MD; Feikin DR; Binka FN; Steele AD; Laserson KF; Ansah NA; Levine MM; Lewis K; Coia ML; Attah-Poku M; Ojwando J; Rivers SB; Victor JC; Nyambane G; Hodgson A; Schödel F; Ciarlet M; Neuzil KM
    Lancet; 2010 Aug; 376(9741):606-14. PubMed ID: 20692030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field trial of rhesus rotavirus vaccine in infants.
    Christy C; Madore HP; Pichichero ME; Gala C; Pincus P; Vosefski D; Hoshino Y; Kapikian A; Dolin R
    Pediatr Infect Dis J; 1988 Sep; 7(9):645-50. PubMed ID: 2845349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.
    Kulkarni PS; Desai S; Tewari T; Kawade A; Goyal N; Garg BS; Kumar D; Kanungo S; Kamat V; Kang G; Bavdekar A; Babji S; Juvekar S; Manna B; Dutta S; Angurana R; Dewan D; Dharmadhikari A; Zade JK; Dhere RM; Fix A; Power M; Uprety V; Parulekar V; Cho I; Chandola TR; Kedia VK; Raut A; Flores J;
    Vaccine; 2017 Oct; 35(45):6228-6237. PubMed ID: 28967523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.
    Ruiz-Palacios GM; Guerrero ML; Bautista-Márquez A; Ortega-Gallegos H; Tuz-Dzib F; Reyes-González L; Rosales-Pedraza G; Martínez-López J; Castañón-Acosta E; Cervantes Y; Costa-Clemens S; DeVos B
    Pediatrics; 2007 Aug; 120(2):e253-61. PubMed ID: 17606534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral vaccination with live attenuated rotavirus].
    Escobar Castro H; Perdomo Giraldi M; Tamáriz-Martel Moreno A; Suárez Cortina L
    An Esp Pediatr; 1988 Jun; 28(6):527-9. PubMed ID: 2848432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial.
    Zaman K; Dang DA; Victor JC; Shin S; Yunus M; Dallas MJ; Podder G; Vu DT; Le TP; Luby SP; Le HT; Coia ML; Lewis K; Rivers SB; Sack DA; Schödel F; Steele AD; Neuzil KM; Ciarlet M
    Lancet; 2010 Aug; 376(9741):615-23. PubMed ID: 20692031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants.
    Laserson KF; Nyakundi D; Feikin DR; Nyambane G; Cook E; Oyieko J; Ojwando J; Rivers SB; Ciarlet M; Neuzil KM; Breiman RF
    Vaccine; 2012 Apr; 30 Suppl 1():A61-70. PubMed ID: 22520138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of RIT 4237 bovine rotavirus vaccine in newborn infants: correlation of vaccine efficacy to season of birth in relation to rotavirus epidemic period.
    Ruuska T; Vesikari T; Delem A; André FE; Beards GM; Flewett TH
    Scand J Infect Dis; 1990; 22(3):269-78. PubMed ID: 2164706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged efficacy of rhesus-human reassortant rotavirus vaccine.
    Joensuu J; Koskenniemi E; Vesikari T
    Pediatr Infect Dis J; 1998 May; 17(5):427-9. PubMed ID: 9613661
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants.
    Clark HF; Bernstein DI; Dennehy PH; Offit P; Pichichero M; Treanor J; Ward RL; Krah DL; Shaw A; Dallas MJ; Laura D; Eiden JJ; Ivanoff N; Kaplan KM; Heaton P
    J Pediatr; 2004 Feb; 144(2):184-90. PubMed ID: 14760258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis.
    Joensuu J; Koskenniemi E; Pang XL; Vesikari T
    Lancet; 1997 Oct; 350(9086):1205-9. PubMed ID: 9652561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.